Molecule Details
| InChIKey | GDTQLZHHDRRBEB-UHFFFAOYSA-N |
|---|---|
| Canonical SMILES | CCCNC(=O)c1cn2ncnc(Nc3cc(C(=O)NC4CC4)ccc3C)c2c1C |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.55 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12696 |
|---|---|
| Drug Name | BMS-582949 |
| CAS Number | 623152-17-0 |
| Groups | investigational |
| ATC Codes | nan |
| Description | BMS-582949 has been investigated for the treatment of Psoriasis. |
Categories: Mitogen-Activated Protein Kinase 14, antagonists & inhibitors
Cross-references: BindingDB: 50327009 CHEMBL1230065 ChemSpider: 8584505 PDB: 38P PubChem:10409068 PubChem:347828897 ZINC: ZINC000036475284